Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ViroMed Co Ltd issues FY 2014 revenue outlook

Tuesday, 14 Jan 2014 08:44pm EST 

ViroMed Co Ltd:Sees revenue and operating profit of 6,154 million and 474 million respectively, for fiscal year 2014. 

Company Quote

600.0 +1.17%
28 Nov 2014